Phospho-JNK1/2/3 (Thr183+Tyr185) Antibody
Source: Rabbit pAb Catalog No. : CY6315
Phospho-JNK1/2/3 (Thr183+Tyr185) Antibody (CY6315)
UniProt:P45983/P45984/P53779
Application:WB
Reactivity:Human,Mouse,Rat
Source:Rabbit pAb
References（2）
http://www.abways.cn/showproduct.asp?cid=CY6315
数据表
-
UniProt
-
Mol Weight46,54kDa
-
Alternative Namesc-Jun N-terminal kinase 3; FLJ12099; FLJ33785; JNK3; JNK3 alpha protein kinase; JNK3A; MAP kinase 10; MAP kinase p49 3F12; MAPK 10; MAPK10; MGC50974; Mitogen-activated protein kinase 10; MK10; p493F12; p54bSAPK; PRKM10; stress activated protein kinase bet
-
ImmunogenA synthesized peptide derived from human JNK1/2/3 around the phosphorylation site of Threonine 183+Tyrosine 185
-
StorageRabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at +4°C short term. Store at -20°C long term. Avoid freeze / thaw cycle.
-
PurificationAffinity-chromatography
-
IsotypeRabbit IgG
-
ClonalityPolyclonal
-
DescriptionJNK3 a protein kinase of the MAPK family that is potently activated by a variety of environmental stress and pro-inflammatory cytokines. Brain-selective JNK isoform.
Applications
-
ReactivityHuman,Mouse,Rat
-
ApplicationWB
-
Recommended dilutionWB 1:500-1:2000
-
Western blot analysis of JNK1/2/3 phosphorylation expression in UV treated 293 whole cell lysates,The lane on the left is treated with the antigen-specific peptide.
引用文献（2条）
Decitabine attenuates dextran sodium sulfate‑induced ulcerative colitis through regulation of immune regulatory cells and intestinal barrier-International Journal of Molecular Medicine (INT J MOL MED)
Protein therapy of skeletal muscle atrophy and mechanism by angiogenic factor AGGF1-Journal of Cachexia Sarcopenia and Muscle
销售咨询
一键电话